TransMedics Group, Inc. Reports Record Third Quarter Revenue and Case Volume
TMDX Transmedics Group Inc
$88.24 +27.92%
View chart & analysis → - 1TransMedics' total third quarter revenue was approximately $203 million, representing a year-over-year increase of approximately 41%.
- 2CEO Waleed Hassanein raised the annual revenue guidance to a range of $764 million to $774 million.
- 3TransMedics achieved growth despite a 6% decrease in industry donated organ volume in the third quarter of 2026.
So what's the key point?
TransMedics' third quarter revenue increased by 41% compared to last year. The company has raised its expected earnings for this year.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.